the doctor or manufacturer of the vaccine could not be considered to have been negligent. Nevertheless, unless a no fault compensation scheme is established such cases are likely to entail parents in considerable expense over a prolonged period and create considerable adverse publicity for rubella vaccination. Indeed, this has occurred recently; it would be unfortunate if such adverse publicity destroys the public's confidence in a remarkably effective and safe vaccine.
The selective rubella vaccination programme in the United Kingdom was recently augmented by the introduction of a combined measles, mumps, and rubella vaccine for children of both sexes. 8 Although this programme will reduce the circulation of rubella in the community and thereby decrease the risk of exposure of pregnant women to the virus, cases of reinfection will probably continue to be diagnosed for some years. Until rubella infection is eradicated consideration must be given to 
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There is no unequivocal evidence that patients with inflammatory bowel disease are at increased risk from bowel preparation with laxatives,4 and in our study
